15.13 USD
-0.19 (-1.24%)
At close: Jan 30, 2026
15.13 USD
0 (0%)
After Hours: 1/30/2026, 8:09:24 PM
Overall NPCE gets a fundamental rating of 2 out of 10. We evaluated NPCE against 185 industry peers in the Health Care Equipment & Supplies industry. NPCE has a bad profitability rating. Also its financial health evaluation is rather negative. NPCE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year NPCE has reported negative net income.
- NPCE had a negative operating cash flow in the past year.
- NPCE had negative earnings in each of the past 5 years.
- NPCE had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of NPCE (-22.36%) is comparable to the rest of the industry.
- NPCE has a worse Return On Equity (-129.53%) than 65.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.36% | ||
| ROE | -129.53% | ||
| ROIC | N/A |
ROA(3y)-33.52%
ROA(5y)-34.1%
ROE(3y)-211.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NPCE has a Gross Margin of 76.77%. This is amongst the best in the industry. NPCE outperforms 88.11% of its industry peers.
- In the last couple of years the Gross Margin of NPCE has remained more or less at the same level.
- NPCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
- NPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NPCE has more shares outstanding
- NPCE has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, NPCE has a worse debt to assets ratio.
2.2 Solvency
- NPCE has an Altman-Z score of -2.62. This is a bad value and indicates that NPCE is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -2.62, NPCE is doing worse than 62.70% of the companies in the same industry.
- A Debt/Equity ratio of 3.17 is on the high side and indicates that NPCE has dependencies on debt financing.
- NPCE has a worse Debt to Equity ratio (3.17) than 84.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.62 |
ROIC/WACCN/A
WACC10.39%
2.3 Liquidity
- NPCE has a Current Ratio of 4.86. This indicates that NPCE is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of NPCE (4.86) is better than 77.30% of its industry peers.
- NPCE has a Quick Ratio of 3.94. This indicates that NPCE is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 3.94, NPCE is doing good in the industry, outperforming 74.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.86 | ||
| Quick Ratio | 3.94 |
3. Growth
3.1 Past
- NPCE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.00%, which is quite impressive.
- The Revenue has grown by 24.08% in the past year. This is a very strong growth!
- NPCE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.67% yearly.
EPS 1Y (TTM)24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.11%
Revenue 1Y (TTM)24.08%
Revenue growth 3Y20.93%
Revenue growth 5Y16.67%
Sales Q2Q%29.89%
3.2 Future
- The Earnings Per Share is expected to grow by 19.32% on average over the next years. This is quite good.
- The Revenue is expected to grow by 18.59% on average over the next years. This is quite good.
EPS Next Y19.74%
EPS Next 2Y13.46%
EPS Next 3Y17.59%
EPS Next 5Y19.32%
Revenue Next Year23.34%
Revenue Next 2Y11.29%
Revenue Next 3Y16.31%
Revenue Next 5Y18.59%
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- NPCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NPCE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as NPCE's earnings are expected to grow with 17.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.46%
EPS Next 3Y17.59%
5. Dividend
5.1 Amount
- No dividends for NPCE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NEUROPACE INC / NPCE FAQ
Can you provide the ChartMill fundamental rating for NEUROPACE INC?
ChartMill assigns a fundamental rating of 2 / 10 to NPCE.
What is the valuation status of NEUROPACE INC (NPCE) stock?
ChartMill assigns a valuation rating of 0 / 10 to NEUROPACE INC (NPCE). This can be considered as Overvalued.
How profitable is NEUROPACE INC (NPCE) stock?
NEUROPACE INC (NPCE) has a profitability rating of 1 / 10.
What is the expected EPS growth for NEUROPACE INC (NPCE) stock?
The Earnings per Share (EPS) of NEUROPACE INC (NPCE) is expected to grow by 19.74% in the next year.